Hussain, Yasin
Drill, Esther
Dang, Chau T.
Liu, Jennifer E.
Steingart, Richard M.
Yu, Anthony F. http://orcid.org/0000-0002-7120-8285
Funding for this research was provided by:
National Cancer Institute (K23 CA218897, P30 CA008748)
National Institutes of Health (UL1 TR-002384)
Article History
Received: 12 December 2018
Accepted: 18 January 2019
First Online: 5 February 2019
Compliance with ethical standards
:
: Dr. Dang receives research funding from Roche/Genentech and GlaxoSmithKline. Dr. Steingart is a consultant for Pfizer and Celgene. Dr. Yu is a consultant for Glenmark Pharmaceuticals. All remaining authors have declared no conflict of interest.
: All procedures were performed in accordance with the ethical standards of the Memorial Sloan Kettering Cancer Center institutional review board and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.